CAT and metabolic syndrome: But in this study we did not detect the activity of Cat S in gastric cancer patients’ serum and thus did not know how much the activity of Cat S was inhibited by cystatin C. These results indicated that angiocardiopathy, dyslipidemia, inflammation and renal diseases had almost little effect on serum Cat S in GC.